The term “probiotic” was derived from Greek and means “for life.” Probiotics are defined as live microorganisms that confer a health benefit to the host when administered in adequate amounts proposed for probiotics. Common probiotics include lactobacilli and bifidobacterial. Also, other microbial species, besides lactic acid bacteria (LAB), like Bacillus subtilis; Propionibacterium spp. and yeasts have been accepted and used as probiotics.
BioCC is a privately owned R&D company (SME), established by food and feed producers and universities with its main goal to creat, develop, implement and commercialize innovative biotechnological solutions for feed, food and dietary supplements by integrating its and international knowledge in the field of microbiology, biochemistry, genetics, metabolomics, genomics, physiology, and medicine.
One part of BioCC portfolio contains probiotics for human health – probiotics focused on cardiovascular diseases, allergies and oxidative stress as well as probiotics for the prevention of the Clostridium difficile infection.
BioCC owns a collection of microbiological strains of human, animal and plant origin. Several strains have been patented and deposited in international culture collections.
BioCC for conforms to the requirements of EN ISO/IEC 17025:2005 as a testing laboratory in the field of food and feeding stuffs microbiological, chemical analyses and blood immunoassays.